Grifols Chair Symposium: Translating Science into the Clinic

Esteve Auditorium, CEK building.

This symposium is a commemorative session on the occasion of the 10th anniversary of the creation of the Grifols Chair Program. Over the last 10 years, the program has provided unprecedented insights into the complexities of cirrhosis and its complications, laying the groundwork for broader applications across a range of disciplines.

Now the symposium will bring together leading experts in translational research to explore how the integration of omics with clinical research has advanced our understanding of chronic liver disease and other inflammatory conditions.

Moreover, the meeting not only marks the renewal of a key research agreement between EF CLIF, IDIBAPS and Hospital Clínic de Barcelona, but also emphasizes the continued commitment to advancing translational research for improved patient outcomes.

More information here

Program

14.30 Registration

Opening Ceremony

15.00 Welcome and opening remarks.

15.05 The EF CLIF view on translational research - Richard Moreau, Director, EF. CLIF

15.15 Introduction to the Grifols Chair and the ENTR-CLIF - Joan Clària, Director of the Grifols Chair, EF CLIF. Hospital Clínic de Barcelona-IDIBAPS.

Session 1: New paradigms in B cell dysfunction and resolution of inflammation - Chair: Manuel Morales-Ruiz, Hospital Clínic de Barcelona-IDIBAPS.

15.25 - New insights into mucosal B cell responses - Andrea Cerutti, ICREA and Hospital del Mar Research Institute.

15.50 New advances in the resolution of inflammation - Nan Chiang, Brigham and Women’s Hospital.

16.15 Coffee break.

Session 2: Advances and trends in omics technologies - Chair: Ramon Bataller, Hospital Clínic de Barcelona-IDIBAPS.

16.45 New frontiers in single-cell and spatial transcriptomics - Anna Pascual-Reguant, CNAG.

17.10 New frontiers in metabolomics. Jose Maria Mato, CIC bioGUNE.

Session 3: Translating research to therapeutics - Chair: Josep Maria Llovet, IDIBAPS and Icahn School of Medicine at Mount Sinai.

17.35 Lessons I have learned on my scientific journey - Bart Staels, University of Lille, Institut Pasteur de Lille, CHU Lille, Inserm U1011-EGID. Co-founder of GENFIT.

18.00 Novel plasma-derived therapies - Montserrat Costa, Grifols.

Closing remarks